This public procurement record has 2 releases in its history.

TenderCancellation

16 Feb 2021 at 17:27

Award

16 Feb 2021 at 10:46

Summary of the contracting process

NHS England has initiated a public procurement process titled "NHS National Generic Pharmaceuticals Interim 2," classified under various medicinal products, with a total value of approximately £18.77 million. This procurement is designed to establish a framework agreement lasting 12 months, with potential extensions up to a maximum of 48 months. The contract period is set to commence on 1st February 2021 and end on 28th February 2022. The procurement method employed is an open procedure, and the tender period concluded on 6th October 2020, with delivery addresses primarily located in Runcorn, England.

This procurement opportunity presents significant growth potential for businesses within the pharmaceutical sector, particularly small and medium-sized enterprises (SMEs). Companies that manufacture or supply generic pharmaceuticals, especially those capable of fulfilling hospital product requirements or oral medication provisions, would be well-suited to compete. Engaging in this tender could enable these businesses to establish long-term relationships with NHS England and expand their market presence within the UK healthcare system.

How relevant is this notice?

Notice Title

NHS National Generic Pharmaceuticals Interim 2

Notice Description

NHS National Generic Pharmaceuticals Interim 2 2020 Offer reference number: CM/PHG/20/5619 Period of framework agreement: 12 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months. The total maximum duration of the framework agreement to be no more than 48 months Potential periods of call-offs under the framework agreement: Hospital only products - All regions: 01/02/2021 to 31/01/2022 Orals (plus non-parenterals) - All regions: 01/03/2021 to 28/02/2022

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-fb12a8e2-17d3-49d5-bb3b-a982582d6e51
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/5cbccead-509c-48ed-9384-016dd54ef316
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33690000 - Various medicinal products

Notice Value(s)

Tender Value
£18,767,757 £10M-£100M
Lots Value
Not specified
Awards Value
£12,327,097 £10M-£100M
Contracts Value
Not specified

Notice Dates

Publication Date
16 Feb 20215 years ago
Submission Deadline
6 Oct 2020Expired
Future Notice Date
Not specified
Award Date
21 Dec 20205 years ago
Contract Period
1 Feb 2021 - 28 Feb 2022 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Cancelled
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England

Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)

Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
51
Supplier Names

Abbvie Ltd

Accord-UK Ltd

Altan Pharma Ltd

Amarox Limited

Aspire Pharma Ltd

AVENTIS PHARMA LIMITED t-a Sanofi

Baxter Healthcare Ltd

Bristol Laboratories Limited

Brown & Burk UK Ltd

Cipla (EU) Limited

Consilient Health Ltd

Crescent Pharma Limited

CST Pharma Limited

Drugsrus Ltd

Essential-Healthcare Ltd

Focus Pharmaceuticals Ltd

Fresenius Kabi Limited

GlaxoSmithKline UK Limited

Glenmark Pharmaceuticals Europe Ltd

Healthcare Pharma Ltd

HFA Healthcare Products Ltd

Kent Pharma Ltd

Laboratorio Reig Jofre SA

Lexon UK Ltd

Macleods Pharma UK Limited

Manx Healthcare Ltd

Martindale Pharma

medac Pharma LLP

Medley Pharma Ltd

Medreich PLC

Mercury Pharmaceuticals Ltd

Milpharm Ltd/aurobinbdo

Morningside Pharmaeuticals

Mylan

Necessity Supplies Limited

Panpharma UK Limited

Pfizer Ltd

Qdem Pharmaceuticals

Ranbaxy (UK) Ltd

Rivopharm UK Ltd

Sandoz Ltd

Sciecure Pharma Limited

Selective Supplies Ltd

Syri Limited (T/A Thame Laboratories)

Teva UK Limited

THORNTON & ROSS LIMITED

Tillomed Laboratories ltd

UpJohn Limited UK

Waymade PLC

Wockhardt UK Limited

Zentiva Pharma UK Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...